BACKGROUND Rhabdomyosarcoma of the uterine cervix is a rare form of soft-tissue sarcoma predominantly affecting young women,with no established standard treatment protocol.CASE SUMMARY This report presents a case of a...
Supported by National Natural Science Foundation of China,No.82271094;Science and Technology Projects in Guangzhou,No.202201020030,No.202201020015 and No.202201010618;Medical Scientific Research Foundation of Guangdong Province of China,No.A2022415.
BACKGROUND Both rhabdomyosarcoma(RMS)and central retinal artery occlusion(CRAO)are rare medical diseases,and their simultaneous occurrence in the same patient is extraordinarily uncommon.This study presents a comprehe...
Introduction: Rhabdomyosarcoma (RMS) is a malignant soft-tissue tumor arising from striated muscle cells. It accounts for 60% - 70% of malignant mesenchymal tumors and 5% of pediatric cancers. Two-thirds of these canc...
BACKGROUND Rhabdomyosarcoma(RMS)of the vagina in postmenopausal women is an extre-mely rare malignant tumor that was originally described as a unique group of soft tissue sarcomas originating from primitive mesenchyma...
BACKGROUND Rhabdomyosarcoma is a tumor of mesenchymal origin.Secondary leukemia is a complication of previous transformation to other hematologic disorders or is a treatment-related acute myeloid leukemia secondary to...
Beijing Municipal Natural Science Foundation,Grant/Award Number:7222054;Beijing Research Ward Project,Grant/Award Number:BCRW202101。
Rhabdomyosarcomas(RMSs)are highly malignant soft-tissue sarcomas.Head and neck RMSs often pose unique challenges to treatment because of their closeness to important structures.We here report a rare case of a 1-year-o...
Malignant mesenchymal tumors (MTM) in children represent 5% to 10% of malignant tumors in children. They constitute a heterogeneous group of tumors of various differentiations depending on their supposed tissue of ori...
Supported by the National Natural Science Foundation of China (No.82171099,No.82000940,No.81970835,No.81800867);the Natural Science Foundation of Shanghai (No.20ZR1409500)。
AIM:To illustrate clinicopathological features of orbital non-rhabdomyosarcoma soft tissue sarcoma(NRSTS),and to compare the treatment outcome between postoperative radiotherapy(RT) and chemotherapy in a retrospective...
supported by the Pyongyang University of Science and Technology(PUST)-UK scholarship,the Williams Fund(Oxford Hospitals Charity,No.0085);the UK national electron bio-imaging centre(No.NT32452);the Marie Sklodowska–Curie Grant Agreement(No.840964).
Confining chemotherapy to tumour sites by means of active targeting nanoparticles(NPs)may increase the treatment effectuality while reducing potential side effects.Cubosomes are one of the next-generation drug deliver...
BACKGROUND Rhabdomyosarcoma is a soft tissue tumor of primitive mesenchymal cells origin,occurring predominantly in children and adolescents,but extremely rare in adults and the data regarding its treatment are sparse...